10X GENOMICS ($TXG) posted quarterly earnings results on Thursday, May 8th. The company reported earnings of -$0.36 per share, beating estimates of -$0.48 by $0.12. The company also reported revenue of $154,880,000, beating estimates of $133,777,469 by $21,102,531.
You can see Quiver Quantitative's $TXG stock page to track data on insider trading, hedge fund activity, congressional trading, and more.
10X GENOMICS Insider Trading Activity
10X GENOMICS insiders have traded $TXG stock on the open market 6 times in the past 6 months. Of those trades, 1 have been purchases and 5 have been sales.
Here’s a breakdown of recent trading of $TXG stock by insiders over the last 6 months:
- ALAN MATEO purchased 40,000 shares for an estimated $445,572
- SERGE SAXONOV (Chief Executive Officer) has made 0 purchases and 3 sales selling 19,727 shares for an estimated $232,351.
- BENJAMIN J. HINDSON (See Remarks) has made 0 purchases and 2 sales selling 10,380 shares for an estimated $130,088.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
10X GENOMICS Hedge Fund Activity
We have seen 141 institutional investors add shares of 10X GENOMICS stock to their portfolio, and 144 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- RA CAPITAL MANAGEMENT, L.P. added 3,279,401 shares (+inf%) to their portfolio in Q4 2024, for an estimated $47,092,198
- MORGAN STANLEY removed 2,551,036 shares (-39.4%) from their portfolio in Q4 2024, for an estimated $36,632,876
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 2,161,775 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $31,043,089
- POINT72 ASSET MANAGEMENT, L.P. removed 1,230,189 shares (-100.0%) from their portfolio in Q4 2024, for an estimated $17,665,514
- D. E. SHAW & CO., INC. added 1,218,598 shares (+inf%) to their portfolio in Q4 2024, for an estimated $17,499,067
- CAMBER CAPITAL MANAGEMENT LP added 1,000,000 shares (+inf%) to their portfolio in Q4 2024, for an estimated $14,360,000
- TWO SIGMA INVESTMENTS, LP added 982,203 shares (+291.2%) to their portfolio in Q4 2024, for an estimated $14,104,435
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
10X GENOMICS Government Contracts
We have seen $7,765,453 of award payments to $TXG over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- CONSUMABLES FOR 10X GENOMICS CHROMIUM CONTROLLER AND 10X GENOMICS CHROMIUM X INSTRUMENTS: $897,016
- 10X GENOMICS XENIUM ANALYZER/10X GENOMICS VISIUM CYTASSIST: $345,109
- CHROMIUM CELL KITS: $315,314
- CHROMIUM CELL KITS: $315,314
- XENIUM ANALYZER. CAT. #1000481. QTY-1 (AMBIS 2230524): $249,999
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
